Literature DB >> 2426463

Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli.

N Tanese, M J Roth, S P Goff.   

Abstract

Portions of the pol gene of Moloney murine leukemia virus (MuLV) were expressed as fusion proteins in Escherichia coli, and the purified proteins were used to elicit antibodies in Escherichia coli, and the purified proteins were used to elicit antibodies in rabbits. The sera were used to examine the mature pol gene products contained in virion particles and identified the reverse transcriptase and a second protein, P46pol, encoded by the 3' portion of the gene. The P46 protein was not phosphorylated and was present at the same molar abundance as the reverse transcriptase. The sera were also used to detect the Pr200gag-pol intracellular precursor protein and to analyze its processing to the mature forms. The proteins formed by several Moloney MuLV mutants were analyzed. Further tests revealed cross-reactivity with Friend MuLV and feline leukemia virus proteins, but not with avian retrovirus proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426463      PMCID: PMC253082     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Biological studies on the Rous sarcoma virus. I. General introduction. II. Review of sources of experimental variation and of methods for their control.

Authors:  W R BRYAN
Journal:  J Natl Cancer Inst       Date:  1955-08       Impact factor: 13.506

2.  Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains.

Authors:  D Grandgenett; T Quinn; P J Hippenmeyer; S Oroszlan
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Activation of an Mg2+-dependent DNA endonuclease of avian myeloblastosis virus alpha beta DNA polymerase by in vitro proteolytic cleavage.

Authors:  D P Grandgenett; M Golomb; A C Vora
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

5.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

6.  Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon.

Authors:  Y Yoshinaka; I Katoh; T D Copeland; S Oroszlan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Relationship of retrovirus polyprotein cleavages to virion maturation studied with temperature-sensitive murine leukemia virus mutants.

Authors:  O N Witte; D Baltimore
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

8.  gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms.

Authors:  S A Edwards; H Fan
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

9.  Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus.

Authors:  J J Kopchick; J Harless; B S Geisser; R Killam; R R Hewitt; R B Arlinghaus
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

10.  A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration.

Authors:  L A Donehower; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more
  29 in total

1.  Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H.

Authors:  A Telesnitsky; S W Blain; S P Goff
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.

Authors:  E C Jørgensen; F S Pedersen; P Jørgensen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting.

Authors:  M J Roth; P Schwartzberg; N Tanese; S P Goff
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.

Authors:  C M Farnet; W A Haseltine
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein.

Authors:  M J Roth
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.

Authors:  P R Donahue; E A Hoover; G A Beltz; N Riedel; V M Hirsch; J Overbaugh; J I Mullins
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

8.  Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.

Authors:  N Tanese; A Telesnitsky; S P Goff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

9.  Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products.

Authors:  Y W Hu; C Y Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

10.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.